Rationale: Despite growing evidence for mitochondria's involvement in cancer, the roles of specific metabolic components outside the respiratory complex have been little explored. We conducted metabolomic studies on mitochondrial DNA (mtDNA)-deficient (ρ0) cancer cells with lower proliferation rates to clarify the undefined roles of mitochondria in cancer growth. Methods and results: Despite extensive metabolic downregulation, ρ0 cells exhibited high glycerol-3-phosphate (G3P) level, due to low activity of mitochondrial glycerol-3-phosphate dehydrogenase (GPD2). Knockout (KO) of GPD2 resulted in cell growth suppression as well as inhibition of tumor progression in vivo. Surprisingly, this was unrelated to the conventional bioenergetic function of GPD2. Instead, multi-omics results suggested major changes in ether lipid metabolism, for which GPD2 provides dihydroxyacetone phosphate (DHAP) in ether lipid biosynthesis. GPD2 KO cells exhibited significantly lower ether lipid level, and their slower growth was rescued by supplementation of a DHAP precursor or ether lipids. Mechanistically, ether lipid metabolism was associated with Akt pathway, and the downregulation of Akt/mTORC1 pathway due to GPD2 KO was rescued by DHAP supplementation. Conclusion: Overall, the GPD2-ether lipid-Akt axis is newly described for the control of cancer growth. DHAP supply, a non-bioenergetic process, may constitute an important role of mitochondria in cancer.

College of Pharmacy Natural Product Research Institute Seoul National University Seoul 08826 Korea

Faculty of Science Charles University Prague Czech Republic

Institute of Biotechnology Czech Academy of Sciences Prague West Czech Republic

Institute of Physiology Czech Academy of Sciences Prague Czech Republic

School of Pharmacy and Medical Science Griffith University Southport Qld Australia

Zobrazit více v PubMed

Ahn CS, Metallo CM. Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab. 2015;3:1. PubMed PMC

Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48:158–67. PubMed PMC

Stein LR, Imai S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab. 2012;23:420–8. PubMed PMC

Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen Y-C. et al. A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans. Science. 2012;337:96–100. PubMed PMC

Houten SM, Wanders RJ. A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation. J Inherit Metab Dis. 2010;33:469–77. PubMed PMC

Warburg O. The Metabolism of Carcinoma Cells. Cancer Res. 1925;9:148–63.

Warburg O. On the Origin of Cancer Cells. Science. 1956;123:309–14. PubMed

Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325–37. PubMed

Hensley CT, Faubert B, Yuan Q, Lev-Cohain N, Jin E, Kim J. et al. Metabolic Heterogeneity in Human Lung Tumors. Cell. 2016;164:681–94. PubMed PMC

Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer. 2005;5:857–66. PubMed

Laurenti G, Tennant DA. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer? Biochem Soc Trans. 2016;44:1111–6. PubMed

Klingenberg M. Localization of the Glycerol-Phosphate Dehydrogenase in the Outer Phase of the Mitochondrial Inner Membrane. Eur J Biochem. 1970;13:247–52. PubMed

Yeh JI, Chinte U, Du S. Structure of glycerol-3-phosphate dehydrogenase, an essential monotopic membrane enzyme involved in respiration and metabolism. Proc Natl Acad Sci U S A. 2008;105:3280–5. PubMed PMC

Schumann U, Subramani S. Special delivery from mitochondria to peroxisomes. Trends Cell Biol. 2008;18:253–6. PubMed PMC

Fransen M, Lismont C, Walton P. The Peroxisome-Mitochondria Connection: How and Why? Int J Mol Sci. 2017. 18. PubMed PMC

Takeuchi K, Reue K. Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am J Physiol Endocrinol Metab. 2009;296:E1195–E209. PubMed PMC

Drahota Z, Chowdhury SK, Floryk D, Mrácek T, Wilhelm J, Rauchová H. et al. Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide. J Bioenerg Biomembr. 2002;34:105–13. PubMed

Mracek T, Pecinova A, Vrbacky M, Drahota Z, Houstek J. High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria. Arch Biochem Biophys. 2009;481:30–6. PubMed

Orr AL, Quinlan CL, Perevoshchikova IV, Brand MD. A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase. J Biol Chem. 2012;287:42921–35. PubMed PMC

Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510:542–6. PubMed PMC

Madiraju AK, Qiu Y, Perry RJ, Rahimi Y, Zhang XM, Zhang D. et al. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med. 2018;24:1384–94. PubMed PMC

Harding JW Jr, Pyeritz EA, Morris HP, White HB 3rd. Proportional Activities of Glycerol Kinase and Glycerol 3-Phosphate Dehydrogenase in Rat Hepatomas. Biochem J. 1975;148:545–50. PubMed PMC

Harding JW Jr, Pyeritz EA, Copeland ES, White HB 3rd. Role of Glycerol 3-Phosphate Dehydrogenase in Glyceride Metabolism. Biochem J. 1975;146:223–9. PubMed PMC

Langston PK, Nambu A, Jung J, Shibata M, Aksoylar HI, Lei J. et al. Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses. Nat Immunol. 2019;20:1186–95. PubMed PMC

Thakur S, Daley B, Gaskins K, Vasko VV, Boufraqech M, Patel D. et al. Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In vitro and In vivo. Clin Cancer Res. 2018;24:4030–43. PubMed PMC

Lu J, Xu Z, Duan H, Ji H, Zhen Z, Li B. et al. Tumor-associated macrophage interleukin-beta promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells. Cancer Sci. 2020;111:1979–90. PubMed PMC

Mikeli M, Fujikawa M, Nagahisa K, Yasuda S, Yamada N, Tanabe T. Contribution of GPD2/mGPDH to an alternative respiratory chain of the mitochondrial energy metabolism and the stemness in CD133-positive HuH-7 cells. Genes Cells. 2020;25:139–48. PubMed

Snyder F. The ether lipid trail: a historical perspective. Biochim Biophys Acta. 1999;1436:265–78. PubMed

Heymans HSA, Schutgens RBH, Tan R, van den Bosch H, Borst P. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome) Nature. 1983;306:69–70. PubMed

Paltauf F. Ether lipids in biomembranes. Chem Phys Lipids. 1994;74:101–39. PubMed

Han X. Lipidomics for studying metabolism. Nat Rev Endocrinol. 2016;12:668–79. PubMed

Honsho M, Yagita Y, Kinoshita N, Fujiki Y. Isolation and characterization of mutant animal cell line defective in alkyl-dihydroxyacetonephosphate synthase: localization and transport of plasmalogens to post-Golgi compartments. Biochim Biophys Acta. 2008;1783:1857–65. PubMed

Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 2012;1822:1442–52. PubMed

Lessig J, Fuchs B. Plasmalogens in Biological Systems: Their Role in Oxidative Processes in Biological Membranes, their Contribution to Pathological Processes and Aging and Plasmalogen Analysis. Curr Med Chem. 2009;16:2021–41. PubMed

Dorninger F, Brodde A, Braverman NE, Moser AB, Just WW, Forss-Petter S. et al. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens. Biochim Biophys Acta. 2015;1851:117–28. PubMed PMC

da Silva TF, Sousa VF, Malheiro AR, Brites P. The importance of ether-phospholipids: a view from the perspective of mouse models. Biochim Biophys Acta. 2012;1822:1501–8. PubMed

Dean JM, Lodhi IJ. Structural and functional roles of ether lipids. Protein Cell. 2018;9:196–206. PubMed PMC

Hajra AK. Dihydroxyacetone phosphate acyltransferase. Biochim Biophys Acta-Lipids Lipid Metab. 1997;1348:27–34. PubMed

Brites P, Waterham HR, Wanders RJ. Functions and biosynthesis of plasmalogens in health and disease. Biochim Biophys Acta. 2004;1636:219–31. PubMed

Rizzo WB, Craft DA, Dammann AL, Phillips MW. Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle. J Biol Chem. 1987;262:17412–9. PubMed

Nagan N, Zoeller RA. Plasmalogens: biosynthesis and functions. Prog Lipid Res. 2001;40:199–229. PubMed

Roos DS, Choppin PW. Tumorigenicity of cell lines with altered lipid composition. Proc Natl Acad Sci U S A. 1984;81:7622–6. PubMed PMC

Benjamin DI, Cozzo A, Ji X, Roberts LS, Louie SM, Mulvihill MM. et al. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc Natl Acad Sci U S A. 2013;110:14912–7. PubMed PMC

Merchant TE, Kasimos JN, de Graaf PW, Minsky BD, Gierke LW, Glonek T. Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy. Int J Colorectal Dis. 1991;6:121–6. PubMed

Gerbig S, Golf O, Balog J, Denes J, Baranyai Z, Zarand A. et al. Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging. Anal Bioanal Chem. 2012;403:2315–25. PubMed

Saito K, Arai E, Maekawa K, Ishikawa M, Fujimoto H, Taguchi R. et al. Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma. Sci Rep. 2016;6:28932. PubMed PMC

Chen X, Chen H, Dai M, Ai J, Li Y, Mahon B. et al. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions. Oncotarget. 2016;7:36622–31. PubMed PMC

Fernandes A, Messias MCF, Duarte GHB, de Santis GKD, Mecatti GC, Porcari AM, Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening. Metabolites. 2020. 10. PubMed PMC

Smith RE, Lespi P, Di Luca M, Bustos C, Marra FA, de Alaniz MJ. et al. A reliable biomarker derived from plasmalogens to evaluate malignancy and metastatic capacity of human cancers. Lipids. 2008;43:79–89. PubMed

Messias MCF, Mecatti GC, Priolli DG, de Oliveira Carvalho P. Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer. Lipids Health Dis. 2018;17:41. PubMed PMC

Tan AS, Baty JW, Dong LF, Bezawork-Geleta A, Endaya B, Goodwin J. et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 2015;21:81–94. PubMed

Bajzikova M, Kovarova J, Coelho AR, Boukalova S, Oh S, Rohlenova K. et al. Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells. Cell Metab. 2019;29:399–416. e10. PubMed PMC

Galili T, O'Callaghan A, Sidi J, Sievert C. heatmaply: an R package for creating interactive cluster heatmaps for online publishing. Bioinformatics. 2018;34:1600–2. PubMed PMC

Nam H, Hong S-S, Jung KH, Kang S, Park MS, Kang S. et al. A Serum Marker for Early Pancreatic Cancer with a Possible Link to Diabetes. JNCI-J Natl Cancer Inst. 2022;114:228–34. PubMed PMC

Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–W60. PubMed PMC

Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A. et al. Tissue-based map of the human proteome. Science. 2015;347:1260419. PubMed

Singh G. Mitochondrial FAD-linked Glycerol-3-phosphate Dehydrogenase: A Target for Cancer Therapeutics. Pharmaceuticals (Basel) 2014;7:192–206. PubMed PMC

Aguer C, Gambarotta D, Mailloux RJ, Moffat C, Dent R, McPherson R. et al. Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells. PLoS One. 2011;6:e28536. PubMed PMC

Dröse S, Brandt U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol. 2012;748:145–69. PubMed

Paul S, Lancaster GI, Meikle PJ. Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic disease. Prog Lipid Res. 2019;74:186–95. PubMed

Honsho M, Asaoku S, Fujiki Y. Posttranslational regulation of fatty acyl-CoA reductase 1, Far1, controls ether glycerophospholipid synthesis. J Biol Chem. 2010;285:8537–42. PubMed PMC

Orozco JM, Krawczyk PA, Scaria SM, Cangelosi AL, Chan SH, Kunchok T. et al. Dihydroxyacetone phosphate signals glucose availability to mTORC1. Nat Metab. 2020;2:893–901. PubMed PMC

da Silva TF, Eira J, Lopes AT, Malheiro AR, Sousa V, Luoma A. et al. Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination. J Clin Invest. 2014;124:2560–70. PubMed PMC

Hossain MS, Ifuku M, Take S, Kawamura J, Miake K, Katafuchi T. Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling. PLoS One. 2013;8:e83508. PubMed PMC

Pike LJ, Han XL, Chung KN, Gross RW. Lipid Rafts Are Enriched in Arachidonic Acid and Plasmenylethanolamine and Their Composition Is Independent of Caveolin-1 Expression: A Quantitative Electrospray Ionization/Mass Spectrometric Analysis. Biochemistry. 2002;41:2075–88. PubMed

Gao X, Lowry PR, Zhou X, Depry C, Wei Z, Wong GW. et al. PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc Natl Acad Sci U S A. 2011;108:14509–14. PubMed PMC

Xie J, Ye J, Cai Z, Luo Y, Zhu X, Deng Y. et al. GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate. Cancer Res. 2020;80:2150–62. PubMed

Wu S, Mao C, Kondiparthi L, Poyurovsky MV, Olszewski K, Gan B. A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria. Proc Natl Acad Sci U S A. 2022;119:e2121987119. PubMed PMC

Brown LJ, Koza RA, Everett C, Reitman ML, Marshall L, Fahien LA. et al. Normal thyroid thermogenesis but reduced viability and adiposity in mice lacking the mitochondrial glycerol phosphate dehydrogenase. J Biol Chem. 2002;277:32892–8. PubMed

Hunt SM, Osnos M, Rivlin RS. Thyroid hormone regulation of mitochondrial alpha-glycerophosphate dehydrogenase in liver and hepatoma. Cancer Res. 1970;30:1764–8. PubMed

Dionisi O, Cittadini A, Gelmuzzi G, Galeotti T, Terranova T. The role of the α-glycerophosphate shuttle in the reoxidation of cytosolic NADH in ehrlich ascites tumour cells. Biochim Biophys Acta-Bioenerg. 1970;216:71–9. PubMed

Mracek T, Drahota Z, Houstek J. The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. Biochim Biophys Acta. 2013;1827:401–10. PubMed

Wu ST, Liu B, Ai ZZ, Hong ZC, You PT, Wu HZ. et al. Esculetin Inhibits Cancer Cell Glycolysis by Binding Tumor PGK2, GPD2, and GPI. Front Pharmacol. 2020;11:379. PubMed PMC

Tretter L, Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J Neurosci. 2004;24:7771–8. PubMed PMC

Schonfeld P, Wieckowski MR, Lebiedzinska M, Wojtczak L. Mitochondrial fatty acid oxidation and oxidative stress: lack of reverse electron transfer-associated production of reactive oxygen species. Biochim Biophys Acta. 2010;1797:929–38. PubMed

Singh H, Beckman K, Poulos A. Exclusive localization in peroxisomes of dihydroxyacetone phosphate acyltransferase and alkyl-dihydroxyacetone phosphate synthase in rat liver. J Lipid Res. 1993;34:467–77. PubMed

Wallner S, Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid species. Chem Phys Lipids. 2011;164:573–89. PubMed

Annunziata I, Sano R, d'Azzo A. Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases. Cell Death Dis. 2018;9:328. PubMed PMC

Dorninger F, Forss-Petter S, Wimmer I, Berger J. Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration. Neurobiol Dis. 2020;145:105061. PubMed PMC

Hossain MS, Mineno K, Katafuchi T. Neuronal Orphan G-Protein Coupled Receptor Proteins Mediate Plasmalogens-Induced Activation of ERK and Akt Signaling. PLoS One. 2016;11:e0150846. PubMed PMC

Maeba R, Sawada Y, Shimasaki H, Takahashi I, Ueta N. Ethanolamine plasmalogens protect cholesterol-rich liposomal membranes from oxidation caused by free radicals. Chem Phys Lipids. 2002;120:145–51. PubMed

Skaff O, Pattison DI, Davies MJ. The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry. 2008;47:8237–45. PubMed

Broniec A, Klosinski R, Pawlak A, Wrona-Krol M, Thompson D, Sarna T. Interactions of plasmalogens and their diacyl analogs with singlet oxygen in selected model systems. Free Radic Biol Med. 2011;50:892–8. PubMed PMC

Gwinn DM, Shaw RJ. AMPK Control of mTOR Signaling and Growth. In: Tamanoi F, Hall MN, Ed. The Enzymes: Academic Press. 2010. pp. 49–75.

Kalender A, Selvaraj A, Kim SY, Gulati P, Brule S, Viollet B. et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab. 2010;11:390–401. PubMed PMC

Buller CL, Heilig CW, Brosius FC 3rd. GLUT1 enhances mTOR activity independently of TSC2 and AMPK. Am J Physiol-Renal Physiol. 2011;301:F588–F96. PubMed PMC

Wolfson RL, Chantranupong L, Wyant GA, Gu X, Orozco JM, Shen K. et al. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature. 2017;543:438–42. PubMed PMC

Roberts DJ, Tan-Sah VP, Ding EY, Smith JM, Miyamoto S. Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. Mol Cell. 2014;53:521–33. PubMed PMC

Zhang CS, Hawley SA, Zong Y, Li M, Wang Z, Gray A. et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature. 2017;548:112–6. PubMed PMC